SCHEMBL4880915

SCHEMBL4880915

COc1cccc(C2(CNS(C)(=O)=O)CCC(NC3CCN(C)CC3)CC2)c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SOAT1 P35610 6/20 0.46
NPY1R P25929 1/20 0.42
NPY5R Q15761 1/20 0.42
KMT2A Q03164 2/20 0.42
SLC6A4 P31645 2/20 0.40
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A3 Q01959 1/20 0.40
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HTR6 P50406 1/20 0.38
SIGMAR1 Q99720 2/20 0.38
CXCR3 P49682 1/20 0.37
KDM1A O60341 1/20 0.37
CHRM5 P08912 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4880910 1.00 SOAT1 (0.46) SOAT1NPY1RNPY5RKMT2ASLC6A4
SCHEMBL4878110 0.91 SOAT1 (0.46) SOAT1NPY1RNPY5RKMT2ASLC6A4
SCHEMBL4878101 0.91 SOAT1 (0.46) SOAT1NPY1RNPY5RKMT2ASLC6A4
SCHEMBL4873608 0.89 SOAT1 (0.42) SOAT1NPY1RNPY5RMTNR1AMTNR1B
SCHEMBL4873595 0.89 SOAT1 (0.42) SOAT1NPY1RNPY5RMTNR1AMTNR1B
SCHEMBL4877592 0.87 SIGMAR1 (0.52) KMT2AMEN1SIGMAR1CXCR3CHRM1
SCHEMBL4877583 0.87 SIGMAR1 (0.52) KMT2AMEN1SIGMAR1CXCR3CHRM1
SCHEMBL14194844 0.87 HTR2C (0.39) SOAT1KMT2ASLC6A4MTNR1AMTNR1B
SCHEMBL4877679 0.86 SOAT1 (0.46) SOAT1KMT2ASLC6A4MTNR1AMTNR1B
Hydrochloric Acid SCHEMBL4873584 0.86 HTR2C (0.40) SOAT1SLC6A4MTNR1AMTNR1BSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096922-A1 Novel Sulfonamide derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2008-04-24 US disclosed
EP-1736467-A1 NOVEL SULFONAMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2006-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096922-A1 Novel Sulfonamide derivative NR4A1, NR4A2, NR4A3 SOAT1 502/4885NPY1R 338/4885NPY5R 535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.